Question

Do you think relaxing the standards is a benefit or potential greater risk for public health for the general population?

To protect public health what should FDA do to prioritize companies with potential helpful therapies?

Answer 1

In my point of view the relaxing standards is a potential risk for public health for the general population.

Inorder to protect public health. FDA take responsibilities by assuring safety, efficacy, security of human and drugs,biological products, our nation's food supply,  

FFDA prioritize companies according to the review of safety and effectiveness of new drugs , approval or pre-approval review.

Post market and post approval regulatory procedure

answered by: anonymous